First link: ...the rate of Bell’s palsy in the clinical trials is lower than the overall rate in the general population... Second: FDA scientists have said tha

First link: ...the rate of Bell’s palsy in the clinical trials is lower than the overall rate in the general population... Second: FDA scientists have said that the documented cases of Bell’s palsy are “consistent with the expected background rate in the general population”... Third: The adverse effects of the vaccine—even if, at worst, they all happen at once—are transient and a normal sign of reactogenicity signaling an effective immune response. But I worry that they could be a major barrier to vaccine uptake. Reading is fundamental.